AI isn’t failing companies because of the technology itself, but because it exposes the underlying weaknesses in their systems, teams and operational complexity that leaders haven’t addressed first.
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Built into the Claude Desktop app, Cowork lets users designate a specific folder where Claude can read or modify files, with further instructions given through the standard chat interface.